Artiva Biotherapeutics Inc
NASDAQ:ARTV

Watchlist Manager
Artiva Biotherapeutics Inc Logo
Artiva Biotherapeutics Inc
NASDAQ:ARTV
Watchlist
Price: 11.11 USD 11.1% Market Closed
Market Cap: 269.9m USD
Have any thoughts about
Artiva Biotherapeutics Inc?
Write Note

Intrinsic Value

The intrinsic value of one ARTV stock under the Base Case scenario is 4.54 USD. Compared to the current market price of 11.11 USD, Artiva Biotherapeutics Inc is Overvalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARTV Intrinsic Value
4.54 USD
Overvaluation 59%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Artiva Biotherapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ARTV
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ARTV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ARTV?
Bearish
Neutral
Bullish

Fundamental Analysis

11.11 USD
+11.1%
+11.1%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Artiva Biotherapeutics Inc
US
Biotechnology
Market Cap
269.8m USD
IPO
Jul 19, 2024
Employees
81
United States of America
Market Cap
269.8m USD
Industry
Biotechnology
IPO
Jul 19, 2024
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Artiva Biotherapeutics Inc

Provide an overview of the primary business activities
of Artiva Biotherapeutics Inc.

What unique competitive advantages
does Artiva Biotherapeutics Inc hold over its rivals?

What risks and challenges
does Artiva Biotherapeutics Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Artiva Biotherapeutics Inc.

Provide P/S
for Artiva Biotherapeutics Inc.

Provide P/E
for Artiva Biotherapeutics Inc.

Provide P/OCF
for Artiva Biotherapeutics Inc.

Provide P/FCFE
for Artiva Biotherapeutics Inc.

Provide P/B
for Artiva Biotherapeutics Inc.

Provide EV/S
for Artiva Biotherapeutics Inc.

Provide EV/GP
for Artiva Biotherapeutics Inc.

Provide EV/EBITDA
for Artiva Biotherapeutics Inc.

Provide EV/EBIT
for Artiva Biotherapeutics Inc.

Provide EV/OCF
for Artiva Biotherapeutics Inc.

Provide EV/FCFF
for Artiva Biotherapeutics Inc.

Provide EV/IC
for Artiva Biotherapeutics Inc.

Show me price targets
for Artiva Biotherapeutics Inc made by professional analysts.

What are the Revenue projections
for Artiva Biotherapeutics Inc?

How accurate were the past Revenue estimates
for Artiva Biotherapeutics Inc?

What are the Net Income projections
for Artiva Biotherapeutics Inc?

How accurate were the past Net Income estimates
for Artiva Biotherapeutics Inc?

What are the EPS projections
for Artiva Biotherapeutics Inc?

How accurate were the past EPS estimates
for Artiva Biotherapeutics Inc?

What are the EBIT projections
for Artiva Biotherapeutics Inc?

How accurate were the past EBIT estimates
for Artiva Biotherapeutics Inc?

Compare the revenue forecasts
for Artiva Biotherapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Artiva Biotherapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Artiva Biotherapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Artiva Biotherapeutics Inc compared to its peers.

Compare the P/E ratios
of Artiva Biotherapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Artiva Biotherapeutics Inc with its peers.

Analyze the financial leverage
of Artiva Biotherapeutics Inc compared to its main competitors.

Show all profitability ratios
for Artiva Biotherapeutics Inc.

Provide ROE
for Artiva Biotherapeutics Inc.

Provide ROA
for Artiva Biotherapeutics Inc.

Provide ROIC
for Artiva Biotherapeutics Inc.

Provide ROCE
for Artiva Biotherapeutics Inc.

Provide Gross Margin
for Artiva Biotherapeutics Inc.

Provide Operating Margin
for Artiva Biotherapeutics Inc.

Provide Net Margin
for Artiva Biotherapeutics Inc.

Provide FCF Margin
for Artiva Biotherapeutics Inc.

Show all solvency ratios
for Artiva Biotherapeutics Inc.

Provide D/E Ratio
for Artiva Biotherapeutics Inc.

Provide D/A Ratio
for Artiva Biotherapeutics Inc.

Provide Interest Coverage Ratio
for Artiva Biotherapeutics Inc.

Provide Altman Z-Score Ratio
for Artiva Biotherapeutics Inc.

Provide Quick Ratio
for Artiva Biotherapeutics Inc.

Provide Current Ratio
for Artiva Biotherapeutics Inc.

Provide Cash Ratio
for Artiva Biotherapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Artiva Biotherapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Artiva Biotherapeutics Inc?

What is the current Free Cash Flow
of Artiva Biotherapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Artiva Biotherapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Artiva Biotherapeutics Inc

Balance Sheet Decomposition
Artiva Biotherapeutics Inc

Current Assets 150.6m
Cash & Short-Term Investments 146.6m
Receivables 701k
Other Current Assets 3.2m
Non-Current Assets 75m
Long-Term Investments 53m
PP&E 21.5m
Other Non-Current Assets 556k
Current Liabilities 13.3m
Accounts Payable 1.2m
Accrued Liabilities 12m
Other Current Liabilities 119k
Non-Current Liabilities 11.3m
Long-Term Debt 75k
Other Non-Current Liabilities 11.2m
Efficiency

Earnings Waterfall
Artiva Biotherapeutics Inc

Revenue
33.7m USD
Operating Expenses
-113.4m USD
Operating Income
-79.7m USD
Other Expenses
1.7m USD
Net Income
-78m USD

Free Cash Flow Analysis
Artiva Biotherapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ARTV Profitability Score
Profitability Due Diligence

Artiva Biotherapeutics Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

19/100
Profitability
Score

Artiva Biotherapeutics Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

ARTV Solvency Score
Solvency Due Diligence

Artiva Biotherapeutics Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Artiva Biotherapeutics Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARTV Price Targets Summary
Artiva Biotherapeutics Inc

Wall Street analysts forecast ARTV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARTV is 21.68 USD with a low forecast of 18.18 USD and a high forecast of 24.15 USD.

Lowest
Price Target
18.18 USD
64% Upside
Average
Price Target
21.68 USD
95% Upside
Highest
Price Target
24.15 USD
117% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ARTV?

Click here to dive deeper.

Dividends

Artiva Biotherapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ARTV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one ARTV stock?

The intrinsic value of one ARTV stock under the Base Case scenario is 4.54 USD.

Is ARTV stock undervalued or overvalued?

Compared to the current market price of 11.11 USD, Artiva Biotherapeutics Inc is Overvalued by 59%.

Back to Top